Computational screening of structurally related impurities for predicted DPP-4 binding affinity
Arhiv za farmaciju · 2026 · 76 (5) · 239-263
DOI: 10.5937/arhfarm76-69309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arhiv za farmaciju, 2026. Verfasst von Petra Đurić und 8 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Process-related impurities and degradation products of dipeptidyl peptidase-4 (DPP-4) inhibitors may retain predicted DPP-4 binding affinity despite being present at trace levels, representing a potential challenge for pharmaceutical quality and safety assessment. The aim of this study was to computationally evaluate DPP-4 docking profiles of structurally related impurities of clinically used gliptins and identify molecular features associated with docking-score variation. A comprehensive dataset comprising 79 process-related impurities and degradation products together with 14 parent DPP-4 inhibitors (93 compounds in total) was investigated using molecular docking with AutoDock Vina. Molecular descriptors calculated using the OCHEM platform were subsequently analyzed by genetic algorithm-multiple linear regression (GA-MLR) to identify molecular features associated with docking-score variation. Docking scores ranged from -12.0 to -4.2 kcal mol-1, with several linagliptinand alogliptin-related impurities exhibiting docking scores comparable to or more favorable than those of their corresponding parent drugs. The developed GA-MLR model demonstrated satisfactory goodness-of-fit and internal validation performance (R² = 0.936, Q² LOO = 0.925, CCC = 0.967) and identified molecular topology, electronic organization, steric complementarity, and charge distribution as molecular features associated with DPP-4 docking behaviour. These findings suggest that preservation of key pharmacophore features, rather than structural similarity alone, contributes to favorable predicted DPP-4 recognition by pharmaceutical impurities. Several structurally related impurities, particularly those associated with linagliptin and alogliptin, retained favorable DPP-4 docking profiles comparable to those of the corresponding parent compounds, supporting their prioritization for subsequent experimental evaluation.
Zitieren
APA
Đurić, P., Obradović, L., Savić, J., Bojanić, N., Marković, B., Vujić, Z., Komsta, Ł., Wicha-Komsta, K., & Obradović, D. (2026). Computational screening of structurally related impurities for predicted DPP-4 binding affinity. Arhiv za farmaciju, 76(5), 239-263. https://doi.org/10.5937/arhfarm76-69309
Vancouver
Đurić P, Obradović L, Savić J, Bojanić N, Marković B, Vujić Z, et al. Computational screening of structurally related impurities for predicted DPP-4 binding affinity. Arhiv za farmaciju. 2026;76(5):239-263. doi:10.5937/arhfarm76-69309
BibTeX
@article{uri2026,
author = {Đurić, Petra and Obradović, Ljiljana and Savić, Jelena and Bojanić, Novica and Marković, Bojan and Vujić, Zorica and Komsta, Łukasz and Wicha-Komsta, Katarzyna and Obradović, Darija},
title = {Computational screening of structurally related impurities for predicted DPP-4 binding affinity},
journal = {Arhiv za farmaciju},
year = {2026},
volume = {76},
number = {5},
pages = {239--263},
doi = {10.5937/arhfarm76-69309}
}
EUVIMED